| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | L-685458 | CCLE | pan-cancer | AAC | -0.0076 | 0.9 |
| mRNA | BRD-K13185470 | CTRPv2 | pan-cancer | AAC | -0.011 | 0.9 |
| mRNA | ML162 | CTRPv2 | pan-cancer | AAC | 0.0055 | 0.9 |
| mRNA | skepinone-L | CTRPv2 | pan-cancer | AAC | -0.0085 | 0.9 |
| mRNA | ETP-46464 | CTRPv2 | pan-cancer | AAC | 0.0068 | 0.9 |
| mRNA | valdecoxib | CTRPv2 | pan-cancer | AAC | -0.0054 | 0.9 |
| mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | 0.0048 | 0.9 |
| mRNA | MS-275 | CTRPv2 | pan-cancer | AAC | -0.0049 | 0.9 |
| mRNA | canertinib | CTRPv2 | pan-cancer | AAC | -0.0053 | 0.9 |
| mRNA | LY-2183240 | CTRPv2 | pan-cancer | AAC | 0.0045 | 0.9 |